Boston Scientific (NYSE:BSX) Target Lowered by Raymond James to $51.00

0
59

Boston Scientific stock has undergone multiple analysts rating changes in the recent past.  stock Target Lowered by Raymond James on 10/28/2021. In a note to investors, the firm issued a new target price of $51.00. The analysts previously had $53.00 target price. Raymond James’s price target would indicate a potential upside of 16.62% from the stock’s previous close.

Shares of traded on Wednesday, reaching $43.52. 1833071 shares of the stock traded hands, compared to its average volume of 5899733. On Wednesday, Shares of closed at $43.52. The firm’s 50 day moving average is $44.11 and its 200 day moving average is $41.84.  has a 12 month low of $32.99 and a 12 month high of $46.29. While on yearly highs and lows, today has traded high as $43.84 and has touched $43.07 on the downward trend.

Earnings and What to expect: 

Boston Scientific last issued its quarterly earnings results on October 26th, 2021. The medical equipment provider reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.01. The company had revenue of $2.93 billion for the quarter, compared to analyst estimates of $2.97 billion. Its revenue was up 10.3% compared to the same quarter last year. Boston Scientific has generated $0.96 earnings per share over the last year ($0.33 diluted earnings per share) and currently has a price-to-earnings ratio of 130.8. Earnings for Boston Scientific are expected to grow by 16.15% in the coming year, from $1.61 to $1.87 per share. Boston Scientific has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, February 2nd, 2022 based off prior year’s report dates.

Earnings for Boston Scientific are expected to grow by 16.15% in the coming year, from $1.61 to $1.87 per share. The P/E ratio of Boston Scientific is 132.52, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 15.12. The P/E ratio of Boston Scientific is 132.52, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 32.49. Boston Scientific has a PEG Ratio of 2.93. PEG Ratios above 1 indicate that a company could be overvalued. Boston Scientific has a P/B Ratio of 4.05. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

(NYSE:BSX) Moving Average Technical Analysis

5 day Moving Average is $$44.09 And 5 day price change is -$1.78 (-3.97%)  with average volume for 5 day average is 4,298,021. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $43.38 and 20 day price change is -$0.30 (-0.69%) and average 20 day moving volume is 5,327,860. 50 day moving average is $44.11  and 50 day price change is -$1.00 ( -2.27%)  and with average volume for 50 days is : 5,672,682. 200 day moving average is $41.84  and 200 day price change is $7.03 (19.50%)  and with average volume for 200 days is : 7,373,600.

Other owners latest trading in Boston Scientific :

  • On 10/28/2021 shares held by SeaTown Holdings Pte. Ltd. were 1,010,000 which equates to market value of $43.82M and appx 1.90% owners of Boston Scientific
  • On 10/28/2021 shares held by Livforsakringsbolaget Skandia Omsesidigt were 61,547 which equates to market value of $2.67M and appx 0.20% owners of Boston Scientific
  • On 10/28/2021 shares held by WINTON GROUP Ltd were 18,780 which equates to market value of $0.82M and appx 0.00% owners of Boston Scientific
  • In total Institutional ownership equates to Institutional Ownership Percentage: 89.80% for Boston Scientific

See More Analyst Rating at: RATING